Allergen-specific antibodies
US11434282B2 · kind B2 · utility
1Cited by
3References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 17, 2021 |
| Grant date | Sep 6, 2022 |
| Priority date | — |
| Expiry date | Jun 17, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In one aspect, methods of generating human monoclonal antibodies that specifically binds to an allergen are provided. In some embodiments, the monoclonal antibodies are generated from sequences identified from isolated single B cells from a human subject who is allergic to the allergen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.